Evidence map›Paper›PMID 34643094›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2021

Control and challenge of COVID-19: lessons from China's experience.

Na Zhu, Wenjie Tan

Abstract readEditorialComment
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Monkeypox Virus and Other Emerging Outbreaks: An Overview and Future Perspective.Inquiry : a journal of medical care organization, provision and financing
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Na ZhuNHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing, China.ORCID 0000-0001-7839-8571
Wenjie TanNHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing, China.

Funding

National Natural Science Foundation of China (NSFC) 82072296
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19ChinaHumansSARS-CoV-2controlcoronavirus disease 2019 (COVID-19)large-scale polymerase chain reaction (PCR)-based testing (LSPT)nonpharmaceutical interventions (NPIs)severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Identifiers

PMID34643094
PMCPMC8598250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.